In contrast, in advanced cancer, TGF-β signaling pathway activation could promote tumor progression through inducing cancer cell migration, invasion, epithelial-mesenchymal transition (EMT), and chemical resistance, thus acting as a carcinogenesis factor (11, 12). This evidence concerns the gene TGFB1 and cancer.